First China Pharmaceutical Group, Inc. October 4, 2010 AMENDMENT TO THE CONVERTIBLE PROMISSORY NOTE DATED OCTOBER 3, 2010
EX-10.1A 3 v212202_ex10-1a.htm Unassociated Document
Exhibit 10.1(a)
THIS CONVERTIBLE PROMISSORY NOTE AND THE SECURITIES ISSUABLE UPON THE CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR UNDER ANY SECURITIES LAWS OF ANY STATE. THEY MAY NOT. BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION IS NOT REQUIRED UNDER. SUCH ACT OR ANY SUCH LAW.
First China Pharmaceutical Group, Inc.
October 4, 2010
AMENDMENT TO THE CONVERTIBLE PROMISSORY NOTE DATED OCTOBER 3, 2010
In accordance with Article 9(b) of the Convertible Promissory Note granted on October 3, 2010 by Sierra Growth Inc. to First China Pharmaceutical Group, Inc, Sierra Growth Inc. hereby assigns the Convertible Promissory Note to Caledonia Partners LLC. This approval of this assignment relinquishes First China Pharmaceutical Group, Inc, from any and all obligations to Sierra Growth Inc. in regard to the Convertible. Promissory Note of October 3, 2010
IN WITNESS WHEREOF, the Company agrees to have the Promissory Note of October 3, 2010 to Caladonia Partners LLC under the same terms and conditions as agreed to with Sierra Growth Inc.
| First China Pharmaceutical Group, Inc. | ||
| By: | /s/ Zhen Jiang Wang | |
| Name: | Zhen Jiang Wang | |
| Title: | Chairman & Chief Executive Officer | |
Agreed and Accepted:
HOLDER Sierra Growth Inc.
| By: | /s/ Josephine Agotilla | |
| Name: | Josephine Agotilla | |
| Title: | Authorized Signatory |
